|
|
European Monitoring Centre for Drugs and Drug Addiction. (2010). Treatment and care for older drug users (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Office for Official Publications of the European Communities.
Abstract: ’Drug problems have no age limits’ – This special review published alongside the 2010 Annual report, reveals why drug use is no longer simply a ‘youth phenomenon’. Europe is experiencing a pronounced ageing of its population, around a quarter of which will be aged 65 or over by 2050. Statistics published today show that Europe’s drug-using population is also ageing and that meeting the needs of older drug users is a growing issue for treatment services. This is particularly the case in western countries which saw the EU’s first heroin epidemics in the 1980s and 1990s.
Keywords: target group; elderly; old age; drug user; addiction; AOD use, abuse, and dependence; chemical addiction; demographic change; treatment and maintenance; health care delivery; Europe
|
|
|
|
Sylvestre, D. L. (2009). Treating HCV in the non-substituted patient. In 1st International Symposium on Hepatitis care in substance users (41). Zurich: O.A.S.I.S. Clinic (Organization to Achieve Solutions in Substance-Abuse).
Keywords: hepatitis C; addiction; AOD dependence; chemical addiction; treatment and maintenance; medical treatment method; United States
|
|
|
|
Liddle, H. A., Dakof, G. A., Turner, R. M., Henderson, C. E., & Greenbaum, P. E. (2008). Treating adolescent drug abuse : a randomized trial comparing multidimensional family therapy and cognitive behavior therapy. Addiction, 103(10; 10/2008), 1660–1670.
Abstract: Aim: to examine the efficacy of two adolescent drug abuse treatments: individual cognitive behavioral therapy (CBT) and multidimensional family therapy (MDFT). Design: A 2 (treatment condition) x 4 (time) repeated-measures intent-to-treat randomized design. Data were gathered at baseline, termination, 6 and 12 months post-termination. Analyses used latent growth curve modeling. Setting: Community-based drug abuse clinic in the northeastern United States. Participants: A total of 224 youth, primarily male (81%), African American (72%), from low-income single-parent homes (58%) with an average age of 15 years were recruited into the study. All youth were drug users, with 75% meeting DSM-IV criteria for cannabis dependence and 13% meeting criteria for abuse. Measurements: Five outcomes were measured: (i) substance use problem severity; (ii) 30-day frequency of cannabis use; (iii) 30-day frequency of alcohol use; (iv) 30-day frequency of other drug use; and (v) 30-day abstinence. Findings: Both treatments produced significant decreases in cannabis consumption and slightly significant reductions in alcohol use, but there were no treatment differences in reducing frequency of cannabis and alcohol use. Significant treatment effects were found favoring MDFT on substance use problem severity, other drug use and minimal use (zero or one occasion of use) of all substances, and these effects continued to 12 months following treatment termination. Conclusion: Both interventions are promising treatments. Consistent with previous controlled trials, MDFT is distinguished by the sustainability of treatment effects.
Keywords: adolescent; AOD abuse; research; treatment and maintenance; treatment method; family therapy; cognitive behavior therapy; randomized controlled trial
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2012). Travel and drug use in Europe : a short review. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Abstract: Recent decades have seen a growth in travel and tourism abroad because of cheap air fares and holiday packages. This has been accompanied by a relaxation of border controls, especially within parts of Europe participating in the Schengen Agreement. As some people may be more inclined to use illicit substances during holiday periods and some may even choose to travel to destinations that are associated with drug use – a phenomenon sometimes referred to as “drug tourism” – this means that from a European drug policy perspective the issue of drug use and travel has become more important.
Keywords: AOD use; AOD associated consequences; public AOD use; drug market; Europe
|
|
|
|
Rel'ier. (2010). Travail social de proximité du canton de Vaud. Zoom : à propos de toxicomanie en région lausannoise, (33; 10/2010), 3.
Keywords: street work; social services; adolescent; woman; prevention; health promotion; risk-taking behavior; interview; French-speaking Switzerland; Vaud; Lausanne; Rel’ier (body)
|
|
|
|
Infodrog (Ed.). (2014). Travail avec les pairs dans le domaine des addictions en Suisse : recommandations. Berne: Infodrog, Centrale nationale de coordination des addictions.
Keywords: peer prevention; peer education; recreational drug use; harm reduction; tertiary prevention; health promotion; treatment; brochure
|
|
|
|
various. (2003). Traumatisierung und Sucht = Trauma and addiction. In 15th International congress on addiction 15. Internationaler Suchtkongress (30). Hamburg.
|
|
|
|
Sezione Comunicazione. (2009). Trattamento basato sull'eroina : base legale a partire dal 1° gennaio 2010 (Ufficio federale della sanità pubblica, Ed.). Berna: Ufficio federale della sanità pubblica (UFSP).
Keywords: legal regulation; treatment and maintenance
|
|
|
|
Ruoss, B. (2006). Transmodulationsblockade. Schweizerische Ärztezeitung, 2006(22; 05/2006), 972–973.
Keywords: residential facility; inpatient care; AOD dependence; opioids in any form; kindling mechanism; detoxification center; voluntary treatment; chemical aversion therapy; hypnotherapy; Zobin, Michael; Moscow; Russia; letter to the editor
|
|
|
|
public health services. (2009). Transkulturelle Prävention und Gesundheitsförderung in der Schweiz : Grundlagen und Empfehlungen (public health services, Ed.). Herzogenbuchsee: Author.
Keywords: public health; prevention; migration; prevention directed at groups; prevention program; policy recommendations; Switzerland
|
|
